Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Evidence: NetEffectContribution: Treatment with opioids for Example for GIN 2022

Generated Narrative: Evidence 179590

version: 4; Last updated: 2023-12-08 13:32:44+0000

Profile: NetEffectContribution

url: https://fevir.net/resources/Evidence/179590

identifier: FEvIR Object Identifier/179590

name: NetEffectContribution_Treatment_with_opioids_for_Example_for_GIN_2022

title: NetEffectContribution: Treatment with opioids for Example for GIN 2022

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

author: Brian S. Alper:

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationComparativeEvidence
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationNetEffectContribution

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

RelatedArtifacts

-TypeCitationResourceReference
*Cite As

NetEffectContribution: Treatment with opioids for Example for GIN 2022 [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179590. Revised 2023-12-04. Available at: https://fevir.net/resources/Evidence/179590. Computable resource at: https://fevir.net/resources/Evidence/179590.

*Amended With Outcome Importance Rating (default value 5) of Treatment with opioids

description:

-0.24 (-0.32 to -0.16)

variableDefinition

description:

Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included).

variableRole: Population

observed: StudyGroup: Severely Obese Adults 2018 Norwegian Cohort

variableDefinition

description:

comparison groups of bariatric surgery vs. no bariatric surgery

variableRole: Exposure

comparatorCategory: no bariatric surgery

observed: GroupAssignment: Bariatric Surgery vs. no bariatric surgery

variableDefinition

description:

Treatment with opioids

variableRole: Outcome

observed: OutcomeVariable: Treatment with opioids

variableDefinition

description:

Relative Importance Multiplier

variableRole: Covariate

roleSubtype: Relative importance multiplier

observed: Relative Importance Multiplier

statistic

description:

risk difference -0.24 (95% CI -0.32 to -0.16)

statisticType: Risk Difference

quantity: -0.24

AttributeEstimates

-DescriptionTypeLevelRange
*

95% CI -0.32 to -0.16

confidence interval0.95-0.32--0.16

ModelCharacteristics

-Code
*Net effect contribution analysis